ArticleRSC advances2022
A label-free aptasensor for clenbuterol detection based on fluorescence resonance energy transfer between graphene oxide and rhodamine B.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 16 citations in OpenAlex.
- Investigating the binding mechanism of aptamers to ochratoxin A and development of competitive colorimetric sensing platforms.Mikrochimica acta · 2025Article
- Real-Time and Selective Detection ofBiosensors · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel label-free aptasensor for the specific detection of clenbuterol was developed through the fluorescence resonance energy transfer (FRET) mechanism by using an aptamer as the target recognition element, rhodamine B (RhoB) as the fluorescence probe and graphene oxide (GO) as the fluorescence quencher. In the absence of clenbuterol, the aptamer was adsorbed on the surface of GO, preventing the interaction between RhoB and GO, and a high fluorescence signal was obtained. In the presence of clenbuterol, the aptamer specially bound to clenbuterol with a high affinity and detached from the surface of GO, while positively charged rhodamine B could be electrostatically adsorbed onto the surface of GO, thus quenching the fluorescence. By comparing the fluorescence intensity before and after the addition of clenbuterol, a simple and fast fluorescence assay for clenbuterol was established with a detection range of 100-700 nM and a detection limit of 9.6 nM. Moreover, the proposed method was successfully applied in the determination of clenbuterol in pork samples with recoveries in the range of 96.75-104.91% and a relative standard deviation of less than 5.67%. Because of its easy operation, fast response, low cost and competitive analytical performance, this method is a promising candidate for the detection of clenbuterol and can be extended to the detection of other targets by changing the corresponding aptamers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.